By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Homology Medicines 

44 Hartwell Avenue

Lexington  Massachusetts  02421   U.S.A.
Phone: 857-305-1825 Fax: n/a


Homology Medicines is based on groundbreaking science that harnesses the naturally occurring process of homologous recombination. This non-nuclease-based approach offers clear advantages in its precision, efficiency and on-target in vivo editing of genetic mutations. Homology obtained an exclusive worldwide license to this technology platform, which is based on the pioneering research of Saswati Chatterjee, Ph.D., Professor of Virology at the Beckman Research Institute at the City of Hope in California, member of the Recombinant DNA Advisory Committee (RAC) to the Office of the Director, National Institutes of Health (NIH) and former charter member of the Therapeutic Approaches to Genetic Diseases Study Section of the NIH. Dr. Chatterjee and her team led the first adeno-associated virus (AAV) vector-mediated gene transfer studies into human hematopoietic stem cells and subsequently identified and isolated a series of naturally-occurring AAVs from human CD34+ cells.




Founder: Saswati Chatterjee

President and CEO: Arthur Tzianabos, Ph.D.

COO: Sam Rasty, Ph.D.

CSO: Albert Seymour, Ph.D.


Please click here for Homology job opportunities.

Key Statistics

Ownership: Private

Web Site: Homology Medicines


Company News
Massachusetts’ Homology Medicines Snags $83.5M to Advance AMEnDR into Human Trials 8/1/2017 6:28:08 AM
Homology Medicines Strengthens Manufacturing And Product Development Expertise With Appointment Of Tim Kelly As Senior Vice President, Technical Operations 5/31/2017 8:21:18 AM
Homology Medicines Presents Data Demonstrating Highly Efficient, On-Target In Vivo Gene Editing Capabilities Of Its Novel Human-Derived Adeno-Associated Virus Vectors 5/15/2017 6:45:21 AM
Homology Medicines Appoints Brad Smith As Chief Financial Officer 4/4/2017 7:27:33 AM
The Next Generation: Top 20 Life Science Startups to Watch in 2017 1/3/2017 3:19:44 PM
What You Need to Know About Homology Medicines 1/3/2017 3:05:50 PM
Homology Medicines Acquires License To Novel AAV Technology To Develop Treatments For Central Nervous System Disorders 9/15/2016 9:58:58 AM